2025 ICD-10-CM code E07.0
Hypersecretion of calcitonin.
Medical necessity for testing and treatment is based on clinical findings, such as elevated calcitonin levels and suspicion of underlying conditions like medullary thyroid cancer.
Clinicians diagnose hypersecretion of calcitonin based on patient history, physical examination, and serum calcitonin level testing. Treatment depends on the underlying cause and may involve surgery, medication, or monitoring.
In simple words: Hypersecretion of calcitonin means your body is making too much calcitonin, a hormone that helps control calcium levels. This can happen with certain thyroid conditions, such as medullary thyroid cancer.
Hypersecretion of calcitonin refers to an increased production of calcitonin, a hormone produced by the thyroid gland's C-cells. Calcitonin helps regulate calcium and phosphorus levels in the blood, primarily by inhibiting bone resorption.This condition can be associated with C-cell hyperplasia or medullary thyroid carcinoma.
Example 1: A patient with a history of thyroid nodules presents with elevated serum calcitonin levels. Further investigation reveals medullary thyroid carcinoma., An older bull displays increased vertebral density. Blood work reveals elevated calcitonin and the presence of a C-cell tumor., During routine blood work, a patient is found to have mildly elevated calcitonin levels.No other symptoms are present, and imaging studies are negative.The patient is monitored for changes in calcitonin levels over time.
Documentation should include serum calcitonin levels, imaging results (e.g., ultrasound, CT scan), and any relevant family history. In cases of medullary thyroid carcinoma, pathology reports should also be documented.
- Specialties:Endocrinology, Oncology
- Place of Service:Office, Inpatient Hospital, Outpatient Hospital